Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Novel antitumor agents from Kyowa Hakko

Jan. 16, 1997

Prokinetic agents disclosed by Zeria

Jan. 16, 1997

Protein tyrosine kinase inhibitors from Kyowa Hakko

Jan. 16, 1997

Tokyo Tanabe discloses beta3-adrenoceptor agonists

Jan. 16, 1997

Searle describes antiinflammatory oxazoles

Jan. 15, 1997

New COX-2 inhibitor series reported by Merck Frosst

Jan. 15, 1997

New PDE IV/TNF inhibitors from Chiroscience

Jan. 15, 1997

PDE IV inhibitors revealed by Byk Gulden

Jan. 15, 1997

New MDR modulators disclosed by Vertex

Jan. 15, 1997

New antimigraine agent from Pfizer

Jan. 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...